Interim report January – March 2023
On April 25, Alligator hosted a webcast for investors, analysts and media, where CEO Søren Bregenholt and CFO Marie Svensson presented and commented on the interim report for January – March 2023.
Click here for a link to the presentation.
LATEST NEWS
Last day of trading in paid subscribed units (Sw. BTU) in Alligator
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, …
Alligator Bioscience to Present Latest Clinical Data from Mitazalimab OPTIMIZE-1 Phase 2 Trial in Pancreatic Cancer at ASCO Annual Meeting 2023
Mitazalimab achieved 52% Objective Response Rate when combined with mFOLFIRINOX in 1st line pancreatic cancer and passed the futility analys …
Bulletin from the annual general meeting in Alligator Bioscience AB on 26 May 2023
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis …